scispace - formally typeset
M

Margaret A. Knowles

Researcher at University of Leeds

Publications -  247
Citations -  18185

Margaret A. Knowles is an academic researcher from University of Leeds. The author has contributed to research in topics: Bladder cancer & Loss of heterozygosity. The author has an hindex of 75, co-authored 242 publications receiving 16801 citations. Previous affiliations of Margaret A. Knowles include St James's University Hospital & University of Southern California.

Papers
More filters
Journal ArticleDOI

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

TL;DR: Improved understanding of molecular features, disease pathogenesis and heterogeneity provides new opportunities for prognostic application, disease monitoring and personalized therapy in urothelial cancer.
Journal ArticleDOI

Lung cancer: intragenic ERBB2 kinase mutations in tumours.

TL;DR: The protein-kinase family is the most frequently mutated gene family found in human cancer and faulty kinase enzymes are being investigated as promising targets for the design of antitumour therapies as mentioned in this paper.
Journal ArticleDOI

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

Nathaniel Rothman, +113 more
- 01 Nov 2010 - 
TL;DR: Two new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1 are identified and previous candidate associations for the GSTM1 deletion and a tag SNP for NAT2 acetylation status are validated, and interactions with smoking in both regions are found.
Journal ArticleDOI

Sequence Variant on 8q24 Confers Susceptibility to Urinary Bladder Cancer

Lambertus A. Kiemeney, +67 more
- 01 Nov 2008 - 
TL;DR: No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers.
Journal ArticleDOI

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.

TL;DR: In this paper, the authors search for mutations at position R132 of the IDH1 gene in a panel of 672 tumor samples, including high-grade glioma, gastrointestinal stromal tumors (GIST), melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, prostate, and thyroid carcinoma specimens.